Email this article The combined ZYTIGA® and prednisone administration increases the overall survival rate in men with the metastatic castration-resistant prostate cancer in the early stages or in cases of the nonaggressive disease state (Munich, Germany)
- Authors: article E.
- Issue: Vol 12, No 2 (2016)
- Pages: 100-101
- Section: CONGRESSES AND CONFERENCES
- Published: 30.06.2016
- URL: https://oncourology.abvpress.ru/oncur/article/view/583
- ID: 583
Cite item
Abstract
.
References
Supplementary files
